83 FR 59388 - Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 226 (November 23, 2018)

Page Range		59388-59389
FR Document		2018-25439

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The meeting will be open to the public; a public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to [email protected] Registration information is available on the website http://www.hhs.gov/ash/carb/ and must be completed by January 23, 2019; all in-person attendees must pre-register by this date. Additional information about registering for the meeting and providing public comment can be obtained at http://www.hhs.gov/ash/carb/ on the Meetings page.

Federal Register, Volume 83 Issue 226 (Friday, November 23, 2018)

[Federal Register Volume 83, Number 226 (Friday, November 23, 2018)]
[Notices]
[Pages 59388-59389]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-25439]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). 
The meeting will be open to the public; a public comment session will 
be held during the meeting. Pre-registration is required for members of 
the public who wish to attend the meeting and who wish to participate 
in the public comment session. Individuals who wish to attend the 
meeting and/or send in their public comment via email should send an 
email to [email protected]. Registration information is available on the 
website http://www.hhs.gov/ash/carb/ and must be completed by January 
23, 2019; all in-person attendees must pre-register by this date. 
Additional information about registering for the meeting and providing 
public comment can be obtained at http://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on January 30, 2019, from 
9:00 a.m. to 5:00 p.m. and January 31, 2019, from 9:00 a.m. to 5:00 
p.m. ET (times are tentative and subject to change). The confirmed 
times and agenda items for the meeting will be posted on the website 
for the Advisory Council at http://www.hhs.gov/ash/carb/ when this 
information becomes available. Pre-registration for attending the 
meeting in person is required to be completed no later than January 23, 
2019; public attendance at the meeting is limited to the available 
space.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW, Washington, 
DC 20201.
    The meeting can also be accessed through a live webcast on the day 
of the meeting. For more information, visit http://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Dr. Jomana Musmar, Acting Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    The public meeting will be dedicated to hosting stakeholders to 
explore priority areas that have emerged since the original National 
Action Plan on Combating Antibiotic Resistant Bacteria was launched in 
2015. The meeting agenda will be posted on the Advisory Council website 
at http://www.hhs.gov/ash/carb/ when it has been finalized. All agenda 
items are tentative and subject to change.

[[Page 59389]]

    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Advisory Council at the address/telephone number listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at http://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing [email protected]. Public 
comments should be sent in by midnight January 23, 2019, and should be 
limited to no more than one page. All public comments received prior to 
January 23, 2019, will be provided to Advisory Council members; 
comments are limited to five minutes per speaker.

    Dated: November 16, 2018.
Tammy R. Beckham,
Acting Director, National Vaccine Program Office.
[FR Doc. 2018-25439 Filed 11-21-18; 8:45 am]
BILLING CODE 4150-44-P

59388 Federal Register / Vol. 83, No. 226 / Friday, November 23, 2018 / Notices

federal government focus in the next DEPARTMENT OF HEALTH AND Department of Health and Human
NAP for CARB—that are not already HUMAN SERVICES Services, Room 715H, Hubert H.
included in the current plan—and why Humphrey Building, 200 Independence
are they the most important? Your Meeting of the Presidential Advisory Avenue SW, Washington, DC 20201.
response can cover a range of priority Council on Combating Antibiotic- Phone: (202) 690–5566; email: CARB@
areas for human, animal, and Resistant Bacteria hhs.gov.
environmental health, including AGENCY: Office of the Assistant
surveillance, research and development, SUPPLEMENTARY INFORMATION: Under
Secretary for Health, Office of the Executive Order 13676, dated
stewardship practices, infection Secretary, Department of Health and
prevention and control practices, and/or September 18, 2014, authority was given
Human Services. to the Secretary of HHS to establish the
other areas for consideration.
ACTION: Notice. Advisory Council, in consultation with
In preparing your response, please be the Secretaries of Defense and
sure to: SUMMARY: As stipulated by the Federal
Agriculture. Activities of the Advisory
Æ Consider how your response fits Advisory Committee Act, the
Council are governed by the provisions
into the existing One Health paradigm, Department of Health and Human
of Public Law 92–463, as amended (5
and how your proposed priority should Services (HHS) is hereby giving notice
U.S.C. App.), which sets forth standards
be further pursued by the U.S. that a meeting is scheduled to be held
for the Presidential Advisory Council on for the formation and use of federal
Government; advisory committees.
Combating Antibiotic-Resistant Bacteria
Æ Provide an answer that is feasible The Advisory Council will provide
(Advisory Council). The meeting will be
and actionable by the U.S. Government; advice, information, and
open to the public; a public comment
Æ Limit your responses to no more session will be held during the meeting. recommendations to the Secretary of
than two priorities for each of the five Pre-registration is required for members HHS regarding programs and policies
goals (a maximum of 10 can be of the public who wish to attend the intended to support and evaluate the
submitted); meeting and who wish to participate in implementation of Executive Order
Æ Summarize your response for each the public comment session. Individuals 13676, including the National Strategy
priority area in 250 words or less, who wish to attend the meeting and/or for Combating Antibiotic-Resistant
including its scientific justification; send in their public comment via email Bacteria and the National Action Plan
Æ Indicate whether your response is should send an email to CARB@hhs.gov. for Combating Antibiotic-Resistant
relevant domestically, internationally, Registration information is available on Bacteria. The Advisory Council shall
or both; the website http://www.hhs.gov/ash/ function solely for advisory purposes.
Æ Indicate the domain(s) to which carb/ and must be completed by January In carrying out its mission, the
your response applies—human, animal, 23, 2019; all in-person attendees must Advisory Council will provide advice,
and/or environmental health; pre-register by this date. Additional information, and recommendations to
information about registering for the the Secretary regarding programs and
Æ Include citations to support your
meeting and providing public comment policies intended to preserve the
response (references must be in the form
can be obtained at http://www.hhs.gov/ effectiveness of antibiotics by
of an active link or citation; we will not
ash/carb/ on the Meetings page. optimizing their use; advance research
accept attachments. Peer-reviewed
citations and journal links are highly DATES: The meeting is scheduled to be to develop improved methods for
encouraged. held on January 30, 2019, from 9:00 a.m. combating antibiotic resistance and
to 5:00 p.m. and January 31, 2019, from conducting antibiotic stewardship;
Response to this RFI is voluntary. 9:00 a.m. to 5:00 p.m. ET (times are strengthen surveillance of antibiotic-
Responders are free to address any or all tentative and subject to change). The resistant bacterial infections; prevent
of the goals listed in the NAP. Please confirmed times and agenda items for the transmission of antibiotic-resistant
note that the USG will not pay for the meeting will be posted on the bacterial infections; advance the
response preparation or for the use of website for the Advisory Council at development of rapid point-of-care and
any information contained in the http://www.hhs.gov/ash/carb/ when this agricultural diagnostics; further research
response. The answers provided in this information becomes available. Pre- on new treatments for bacterial
RFI must not include any confidential registration for attending the meeting in infections; develop alternatives to
or proprietary data. Responses to this person is required to be completed no antibiotics for agricultural purposes;
notice are not offers and cannot be later than January 23, 2019; public maximize the dissemination of up-to-
accepted by the USG to form a binding attendance at the meeting is limited to date information on the appropriate and
contract or issue a grant. Please be the available space. proper use of antibiotics to the general
aware that your comments will not be public and human and animal
ADDRESSES: U.S. Department of Health
posted publicly, however, they may be healthcare providers; and improve
and Human Services, Hubert H.
made available to the public, in part or international coordination of efforts to
Humphrey Building, Great Hall, 200
in full, subject to applicable laws and combat antibiotic resistance.
Independence Avenue SW, Washington,
regulations.
DC 20201. The public meeting will be dedicated
More information can be found at The meeting can also be accessed to hosting stakeholders to explore
www.hhs.gov/ash/carb. through a live webcast on the day of the priority areas that have emerged since
Dated: November 13, 2018. meeting. For more information, visit the original National Action Plan on
amozie on DSK3GDR082PROD with NOTICES1

Jomana F. Musmar, http://www.hhs.gov/ash/carb/. Combating Antibiotic Resistant Bacteria
Acting Designated Federal Officer, FOR FURTHER INFORMATION CONTACT: Dr. was launched in 2015. The meeting
Presidential Advisory Council on Combating Jomana Musmar, Acting Designated agenda will be posted on the Advisory
Antibiotic-Resistant Bacteria Committee Federal Officer, Presidential Advisory Council website at http://www.hhs.gov/
Manager. Council on Combating Antibiotic- ash/carb/ when it has been finalized.
[FR Doc. 2018–25435 Filed 11–21–18; 8:45 am] Resistant Bacteria, Office of the All agenda items are tentative and
BILLING CODE 4150–44–P Assistant Secretary for Health, U.S. subject to change.

VerDate Sep<11>2014 18:33 Nov 21, 2018 Jkt 247001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\23NON1.SGM 23NON1

Federal Register / Vol. 83, No. 226 / Friday, November 23, 2018 / Notices 59389

Public attendance at the meeting is Contact Person: Julia Berzhanskaya, Ph.D., Extramural Policy and Review, National
limited to the available space. Scientific Review Officer, Office of Institute on Drug Abuse, National Institutes
Individuals who plan to attend and Extramural Policy and Review, Division of of Health, DHHS, 6001 Executive Boulevard,
Extramural Research, National Institute on Room 4238, MSC 9550, Bethesda, MD 20892,
need special assistance, such as sign Drug Abuse, NIH, DHHS, 6001 Executive 301–827–5820, hiromi.ono@nih.gov.
language interpretation or other Boulevard, Room 4234, MSC 9550, Bethesda, Name of Committee: National Institute on
reasonable accommodations, should MD 20892, 301–827–5840, Drug Abuse Special Emphasis Panel;
notify the Advisory Council at the julia.berzhanskaya@nih.gov. Advancing Exceptional Research on HIV/
address/telephone number listed above This notice is being published less than 15 AIDS and Substance Abuse (R01, Clinical
at least one week prior to the meeting. days prior to the meeting due to the timing Trial Optional).
For those unable to attend in person, a limitations imposed by the review and Date: December 13, 2018.
live webcast will be available. More funding cycle. Time: 12:00 p.m. to 4:00 p.m.
information on registration and Name of Committee: National Institute on Agenda: To review and evaluate grant
Drug Abuse Special Emphasis Panel; Multi- applications.
accessing the webcast can be found at Place: National Institutes of Health,
Site Studies for System-Level
http://www.hhs.gov/ash/carb/. Implementation of Substance Use Prevention Neuroscience Center, 6001 Executive
Members of the public will have the and Treatment Services (R01; R34). Boulevard, Rockville, MD 20852 (Telephone
opportunity to provide comments prior Date: November 27, 2018. Conference Call).
to the Advisory Council meeting by Time: 1:00 p.m. to 4:30 p.m. Contact Person: Gerald L. McLaughlin,
emailing CARB@hhs.gov. Public Agenda: To review and evaluate grant Ph.D., Scientific Review Officer, Office of
comments should be sent in by applications. Extramural Policy and Review, National
midnight January 23, 2019, and should Place: National Institutes of Health, Institute on Drug Abuse, NIH, DHHS, 6001
be limited to no more than one page. All Neuroscience Center, 6001 Executive Executive Blvd., Room 4238, MSC 9550,
Boulevard, Rockville, MD 20852 (Telephone Bethesda, MD 20892–9550, 301–827–5819,
public comments received prior to gm145a@nih.gov.
Conference Call).
January 23, 2019, will be provided to Contact Person: Julia Berzhanskaya, Ph.D., (Catalogue of Federal Domestic Assistance
Advisory Council members; comments Scientific Review Officer, Office of Program Nos.: 93.279, Drug Abuse and
are limited to five minutes per speaker. Extramural Policy and Review, Division of Addiction Research Programs, National
Dated: November 16, 2018. Extramural Research, National Institute on Institutes of Health, HHS)
Drug Abuse, NIH, DHHS, 6001 Executive
Tammy R. Beckham,
Boulevard, Room 4234, MSC 9550, Bethesda, Dated: November 16, 2018.
Acting Director, National Vaccine Program MD 20892, 301–827–5840, Natasha M. Copeland,
Office. julia.berzhanskaya@nih.gov.
Program Analyst, Office of Federal Advisory
[FR Doc. 2018–25439 Filed 11–21–18; 8:45 am] This notice is being published less than 15
Committee Policy.
BILLING CODE 4150–44–P days prior to the meeting due to the timing
limitations imposed by the review and [FR Doc. 2018–25427 Filed 11–21–18; 8:45 am]
funding cycle. BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND Name of Committee: National Institute on
HUMAN SERVICES Drug Abuse Special Emphasis Panel;
Workshops on the Use of Adolescent Brain DEPARTMENT OF HEALTH AND
National Institutes of Health Cognitive Development (ABCD) Data (R25 HUMAN SERVICES
Clinical Trial Not Allowed).
National Institute on Drug Abuse; Date: November 29, 2018. National Institutes of Health
Notice of Closed Meetings Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant National Institute on Drug Abuse;
Pursuant to section 10(d) of the applications. Notice of Closed Meeting
Federal Advisory Committee Act, as Place: National Institutes of Health,
amended, notice is hereby given of the Neuroscience Center, 6001 Executive Pursuant to section 10(d) of the
following meetings. Boulevard, Rockville, MD 20852 (Telephone Federal Advisory Committee Act, as
The meetings will be closed to the Conference Call). amended, notice is hereby given of the
Contact Person: Julia Berzhanskaya, Ph.D., following meeting.
public in accordance with the Scientific Review Officer, Office of
provisions set forth in sections The meeting will be closed to the
Extramural Policy and Review, Division of public in accordance with the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Extramural Research, National Institute on
as amended. The grant applications and Drug Abuse, NIH, DHHS, 6001 Executive provisions set forth in sections
the discussions could disclose Boulevard, Room 4234, MSC 9550, Bethesda, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
confidential trade secrets or commercial MD 20892, 301–827–5840, as amended. The contract proposals and
property such as patentable material, julia.berzhanskaya@nih.gov. the discussions could disclose
and personal information concerning This notice is being published less than 15 confidential trade secrets or commercial
days prior to the meeting due to the timing property such as patentable material,
individuals associated with the grant limitations imposed by the review and
applications, the disclosure of which and personal information concerning
funding cycle. individuals associated with the contract
would constitute a clearly unwarranted Name of Committee: National Institute on
invasion of personal privacy. proposals, the disclosure of which
Drug Abuse Special Emphasis Panel;
would constitute a clearly unwarranted
Name of Committee: National Institute on Mechanism for Time-Sensitive Drug Abuse
Research (R21 Clinical Trial Optional). invasion of personal privacy.
Drug Abuse Special Emphasis Panel; NIDA
Research Education Program for Clinical Date: December 5, 2018. Name of Committee: National Institute on
Researchers and Clinicians (R25). Time: 12:00 p.m. to 2:00 p.m. Drug Abuse Special Emphasis Panel;
amozie on DSK3GDR082PROD with NOTICES1

Date: November 27, 2018. Agenda: To review and evaluate grant Pharmacokinetic Analysis Resource Center
Time: 10:00 a.m. to 12:30 p.m. applications. (8947).
Agenda: To review and evaluate grant Place: National Institutes of Health, Date: January 8, 2019.
applications. Neuroscience Center, 6001 Executive Time: 11:00 a.m. to 1:00 p.m.
Place: National Institutes of Health, Boulevard, Rockville, MD 20852 (Telephone Agenda: To review and evaluate contract
Neuroscience Center, 6001 Executive Conference Call). proposals.
Boulevard, Rockville, MD 20852 (Telephone Contact Person: Hiromi Ono, Ph.D., Place: National Institutes of Health,
Conference Call). Scientific Review Officer, Office of Neuroscience Center, 6001 Executive

VerDate Sep<11>2014 18:33 Nov 21, 2018 Jkt 247001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\23NON1.SGM 23NON1

Document Created: 2018-11-27 12:59:05
Document Modified: 2018-11-27 12:59:05

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		The meeting is scheduled to be held on January 30, 2019, from 9:00 a.m. to 5:00 p.m. and January 31, 2019, from 9:00 a.m. to 5:00 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the Advisory Council at http://www.hhs.gov/ash/carb/ when this information becomes available. Pre-registration for attending the meeting in person is required to be completed no later than January 23, 2019; public attendance at the meeting is limited to the available space.
Contact		Dr. Jomana Musmar, Acting Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic- Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation		83 FR 59388